Prediction of response and early progression in atezolizumab plus bevacizumab therapy for hepatocellular carcinoma focused on tumor marker trendsNorikazu Tanabe,Issei Saeki,Maho Egusa,Natsuko Nishiyama,Tsuyoshi Fujioka,Daiki Kawamoto,Ryo Sasaki,Tatsuro Nishimura,Toshihiko Matsumoto,Tsuyoshi Ishikawa,Takahiro Yamasaki,Taro TakamiHEPATOLOGY(2023)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要